Analysis begins with heartbeat detection, using identifiable R waves as timing landmarks. Successive R-wave intervals are then compared across the recording to reveal beat-to-beat variability, premature beats, pauses, or sustained episodes. Rather than treating every irregular interval as disease, this pattern-based view helps separate ordinary rhythm variation from persistent or repeated abnormal activity.
Because each R wave marks a heartbeat in the recording, the interval to the next R wave supplies a time-based measure of rhythm regularity. Shortened intervals can indicate premature beats, while prolonged gaps can identify pauses. Examining these intervals across many beats allows investigators to quantify variability and describe whether irregularity is isolated, recurrent, or sustained.
Burden captures how much of a recording is occupied by arrhythmic activity, whereas episode duration shows how long an individual event persists. Considering both prevents a pattern of many brief events from being treated as equivalent to one prolonged episode. Together, these measures give a more informative view of rhythm severity and support comparisons across experiments or treatment conditions.
A practical workflow starts with an ECG recording, followed by heartbeat detection and identification of successive R waves. The resulting intervals are measured to calculate beat-to-beat variability. Analysts then classify patterns such as premature beats, pauses, and sustained episodes, and summarize frequency, duration, burden, and severity. This sequence converts a continuous trace into comparable quantitative descriptors for biological experiments.
Useful outputs include arrhythmia burden, episode duration, beat-to-beat variability, and counts or descriptions of premature beats and pauses. These measures answer different questions: burden indicates overall exposure during the recording, duration characterizes persistence, and variability reveals irregularity between adjacent beats. Reporting them together preserves distinctions that a single summary value could obscure.
In biology, these measurements let researchers track cardiac physiology and disease progression with objective rhythm data. The same metrics can be compared before and after a treatment to assess response, or across organisms and conditions to investigate genetic and environmental influences on cardiac electrical conduction. This makes the approach useful for linking rhythm phenotypes with experimental variables and outcomes.